THERAPEUTIC EDUCATION of SEXUAL DYSFUNCTIONS in WOMEN SURVIVORS of SEXUAL VIOLENCE and FEMALE GENITAL MUTILATION

Not Applicable

Not yet recruiting

• Conditions: Sexual Abuse of Adult (If Focus of Attention is on Victim); Sexual Dysfunction Female; Female Genital Mutilation

• Registration Number: NCT06721325
• Lead Sponsor: University of Alcala

Brief Summary

Violence against women is a problem that affects women all over the planet, causing physical, emotional, and other repercussions for its survivors. Pelvic floor dysfunctions, especially female sexual dysfunctions, are among the most common physical consequences for women who have suffered sexual violence or female genital mutilation. Pelvic floor physiotherapy is the first-line treatment for these dysfunctions, with therapeutic education being one of its main strategies due to its importance in the cognitive approach and for promoting patient adherence to the proposed treatments. Women who are survivors of sexual violence and female genital mutilation, being at risk for these disorders, express the need to receive information about these dysfunctions and their possible treatments. However, it has been shown that their knowledge in this regard is limited. Therefore, a project is proposed with the objective of determining the effectiveness of an intervention based on therapeutic education in the prevention and management of sexual dysfunctions secondary to sexual violence or female genital mutilation. A group educational program is proposed, which allows survivor women to address these dysfunctions in a non-invasive way. Six sessions are planned to promote the development of various competencies: communicating their needs, integrating knowledge about their health problem, identifying and analyzing, decision-making and know-how, problem-solving, using healthcare resources and asserting their rights. This will provide these women a safe space to share their experiences, learn to manage them, acquire knowledge about the pelvic floor, related dysfunctions and their treatment, as well as self-efficacy tools for dealing with sexual dysfunctions.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2024-07-17
• Status Verified: 2024-11
• Study Start: 2024-11-30
• Study First Submitted QC: 2024-12-05
• Last Update Submitted: 2024-12-05
• Study First Posted: 2024-12-06
• Last Update Posted: 2024-12-06
• Primary Completion: 2026-12-31
• Study Completion: 2026-12-31

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: Female
• Target Recruitment: 163

Inclusion Criteria

Women who have suffered sexual assault:

• Aged 18 and older
• No severe psychiatric disorders or any other condition that prevents them from answering questions and questionnaires
• Emotionally prepared to address the affected physical and sexual sphere

Women who have undergone Female Genital Mutilation:

• Aged 18 and older
• No severe psychiatric disorders or inability to answer questions and questionnaires
• Emotionally prepared to address the affected physical and sexual sphere

Exclusion Criteria

• Women who have suffered sexual assaults in the context of trafficking of women and girls for sexual exploitation.
• Women who have difficulty understanding the Spanish language.
• Women who are not psychologically prepared to address their sexuality.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Female Sexual Function Index	Before intervention (A0); immediately after completing the intervention (A1), and at 3 months (A2), 6 months (A3), and 12 months (A4) following A1.	Assessed using the Spanish version of the FSFI. The FSFI is a 19-item questionnaire that evaluates sexual function across six domains: desire, arousal, lubrication, orgasm, satis-faction, and pain. Each domain is scored from 0 to 5, with higher scores indicating better sexual function. The total FSFI score ranges from 2 to 36, with higher scores reflecting improved sexual function.

Secondary Outcome Measures

Name	Time	Method
Treatment Satisfaction	After completing the intervention (A1), and at 3 months (A2), 6 months (A3), and 12 months (A4) following A1	Satisfaction with the treatment will be assessed using a numerical verbal scale ranging from 0 to 10, where 0 represents no satisfaction and 10 indicates ex-cellent satisfaction. This evaluation will begin with assessment A1.